Examination of peripheral basal and reactive cortisol levels in major depressive disorder and the burnout syndrome: A systematic review.


Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
07 2020
Historique:
received: 14 10 2019
revised: 27 01 2020
accepted: 19 02 2020
pubmed: 24 2 2020
medline: 22 6 2021
entrez: 24 2 2020
Statut: ppublish

Résumé

It is debated as to whether major depressive disorder (MDD) and the burnout syndrome represent different aspects of the same syndrome or whether they reflect separate entities. A dysregulation of the hypothalamus-pituitary-adrenal-axis has been related to both conditions separately. Dissecting the pathophysiology of the conditions and describing differences and similarities with regard to stress physiological systems might further clarify whether underlying etiological models of these syndromes differ. A systematic literature search including MDD and the burnout syndrome and peripheral cortisol measures was performed and resulted in 190 studies for inclusion in the qualitative synthesis. For MDD, findings suggest a general state of hypercortisolism and glucocorticoid resistance reflected by increased basal cortisol levels, reduced reactivity to psychosocial stress and a reduced cortisol suppression in pharmacological challenge tests. For the burnout syndrome, two central factors limit further conclusions: i) there is not a sufficient amount of studies examining the burnout syndrome and different cortisol secretion patterns to provide an evidence base, ii) the burnout syndrome is assessed heterogeneously reflecting imprecision of the measured constructs. Large prospective cohort studies examining both conditions in parallel rigorously controlling for confounders are required to further elucidate the differences and similarities of the HPA axis in MDD and the burnout syndrome.

Identifiants

pubmed: 32088345
pii: S0149-7634(19)30944-3
doi: 10.1016/j.neubiorev.2020.02.024
pii:
doi:

Substances chimiques

Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

232-270

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None declared.

Auteurs

N Rothe (N)

Biopsychology, Technische Universität Dresden, Dresden, Germany.

J Steffen (J)

Biopsychology, Technische Universität Dresden, Dresden, Germany.

M Penz (M)

Biopsychology, Technische Universität Dresden, Dresden, Germany; University Hospital Dresden, Clinic and Polyclinic for Psychotherapy and Psychosomatics, Dresden, Germany.

C Kirschbaum (C)

Biopsychology, Technische Universität Dresden, Dresden, Germany.

A Walther (A)

Biopsychology, Technische Universität Dresden, Dresden, Germany; Clinical Psychology and Psychotherapy, University of Zurich, Zurich, Switzerland. Electronic address: a.walther@psychologie.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH